EGFR-IN-29
EGFR-IN-29 is a potent EGFR inhibitor, example J-022, extracted from Patent WO2021160087[1].
Product Specifications
CAS Number
2682200-93-5
UNSPSC
12352005
Target
EGFR
Type
Reference compound
Related Pathways
JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/egfr-in-29.html
Solubility
10 mM in DMSO
Smiles
O=P(C)(C)C1=C2C=CC(C3CC3)=NC2=CC=C1NC4=NC(NC5=C(OC)C=C(N6CCC(CC6)N7CCN(CC7)C)C(C)=C5)=NC=C4Br
Molecular Formula
C36H46BrN8O2P
Molecular Weight
733.68
References & Citations
[1]Xiangyong Liu. Quinolyl phosphine oxide compound, and composition and application thereof. Patent WO2021160087.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
EGFR/ErbB1/HER1
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
